Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Tema Obesity & Cardiometabolic ETF (HRTS)

27.64
0.00
(0.00%)
As of 10:51:48 AM EDT. Market Open.

Performance Overview: HRTS

Trailing returns as of 4/15/2025. Category is Health.

YTD Return

HRTS
4.26%
Category
1.46%

1-Year Return

HRTS
11.00%
Category
6.28%

3-Year Return

HRTS
0.00%
Category
1.28%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
HRTS
Category
YTD
1.07%
-1.46%
1-Month
-5.10%
-5.16%
3-Month
1.07%
-1.46%
1-Year
-12.68%
-6.28%
3-Year
0.00%
-1.28%
5-Year
0.00%
6.84%
10-Year
0.00%
5.31%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
HRTS
Category
2024
-4.30%
0.96%

ETF Summary

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

ETF Overview

Category Health
Fund Family Tema Global Limited
Net Assets 60.02M
YTD Daily Total Return -4.26%
Yield 0.48%
Legal Type Exchange Traded Fund

Related Tickers